Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BGR-34
- Development stage
- Unknown
- Lead developer
- Aimil
- Administration
- Oral
01
Overview
BGR-34 (Blood Glucose Regulator-34) is an Ayurvedic polyherbal formulation developed by India's National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP) under the patronage of the Council of Scientific and Industrial Research (CSIR). Launched commercially by Aimil Pharmaceuticals in 2016, it is indicated for the management of type 2 diabetes. The formulation is derived from six medicinal plants: Daruharidra (*Berberis aristata*), Giloy (*Tinospora cordifolia*), Vijaysar (*Pterocarpus marsupium*), Gudmar (*Gymnema sylvestre*), Manjeestha (*Rubia cordifolia*), and Methi (*Trigonella foenum-graecum*). BGR-34 is reported to act as a natural dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood glucose levels while also exerting antioxidant and cardioprotective actions.
- Brand names
- BGR-34BGR34BGR 34
- Other names
- Blood Glucose Regulator-34
02
Targets
AMY (Pancreatic alpha-amylase)Sucrase-Isomaltase
Beyond the preview
Go deeper on BGR-34.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BGR-34.